SEC Filings

Filing date	Form	Description	View
09/11/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-15-064659.pdf 0001104659-15-064659.rtf 0001104659-15-064659.xls
09/11/15	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-15-064661.pdf 0001104659-15-064661.rtf
09/23/15	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-15-066720.pdf 0001104659-15-066720.rtf
09/30/15	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-15-068319.pdf 0001104659-15-068319.rtf
10/07/15	4	Statement of changes in beneficial ownership of securities	View HTML 0000903423-15-000581.pdf 0000903423-15-000581.rtf 0000903423-15-000581.xls
10/13/15	8-K/A	Amendment to a previously filed 8-K	View HTML 0001104659-15-070210.pdf 0001104659-15-070210.rtf 0001104659-15-070210.xls
10/23/15	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-15-014207.pdf 0001179110-15-014207.rtf 0001179110-15-014207.xls
10/23/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014212.pdf 0001179110-15-014212.rtf 0001179110-15-014212.xls
10/26/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-15-072604.pdf 0001104659-15-072604.rtf 0001104659-15-072604.xls
10/26/15	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-15-008037.pdf 0001047469-15-008037.rtf 0001047469-15-008037.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools